FDA Inspection 566272 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 1000161089

The FDA completed an inspection of Mary Bird Perkins Cancer Center on Mar 2, 2009 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 2, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.